Adel Nada

Amministratore Delegato presso GentiBio, Inc.

Health Technology

Consumer Services

Profilo

Adel Nada is the founder of GentiBio, Inc. He is currently an Independent Director at Alia Therapeutics Srl since 2023.
Previously, he worked as Vice President-Immunotherapy at Caladrius Biosciences, Inc. Dr. Nada has a graduate degree from Rush University and a doctorate degree from Alexandria University.

Posizioni attive di Adel Nada

Società	Posizione	Inizio
GentiBio, Inc. GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA.	Amministratore Delegato	-
Alia Therapeutics Srl Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy.	Direttore/Membro del Consiglio	09/05/2023

Tutte le posizioni attive di Adel Nada

Precedenti posizioni note di Adel Nada

Società	Posizione	Fine
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Adel Nada

Formazione di Adel Nada

Alexandria University	Doctorate Degree
Rush University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Adel Nada

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.	Health Technology
GentiBio, Inc. GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA.	Health Technology
Alia Therapeutics Srl Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy.	Health Technology

Vedi le connessioni aziendali